Biokeralty Research Institute AIE

BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas. The main research areas are: nanotechnology, chronic diseases, regenerative medicine, cancer, personalized medicine or digital health, as well as health value, social care and community care.

Thanks to its multidisciplinary team and its privileged geographical location, BioKeralty constitutes a linkage between the European Research Area (ERA) and the healthcare, social and community reality of those countries where Keralty group provides its services to more than 7 million people worldwide. This opens access to patients, cohorts, clinical validaton and data in countries like Colombia and the USA Since the start of its activity in 2009, BioKeralty has developed open innovation based on a network of worldwide recognized partners, sharing and creating knowledge and technology for the benefit of Keralty group’s users and the society as a whole.

As a result of this collaborative spirit, BioKeralty has achieved a significant position in several research and development areas in Europe, being the results achieved in Horizon 2020 and Horizon Europe research programs an evidence of this fact. Most succesful applications have been based on the application of nanotechnology in health, including cancer, neuro degeneration, etc. Keralty group provides healthcare to 9 million people Worldwide and counts with an excellent position to provide cohorts, data and pilot scenarios.